## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce calcitonin. The treatment of MTC often involves a combination of surgical and medical interventions. Understanding the underlying biology and treatment options for MTC is crucial for managing the disease effectively.

## **Why the Correct Answer is Right**
The correct answer, ., indicates that the treatment of medullary carcinoma of the thyroid primarily involves surgery. Surgery is the mainstay of treatment for MTC, aiming for complete removal of the tumor. This may include total thyroidectomy and dissection of the central lymph nodes, sometimes extended to the lateral neck nodes if there's evidence of lymph node involvement. The goal is to achieve biochemical cure and prevent recurrence.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while radioactive iodine ablation is a treatment modality for some types of thyroid cancer, MTC cells do not typically take up iodine due to their origin from parafollicular C cells, making radioactive iodine therapy ineffective.
- **Option B:** This option is incorrect as it does not accurately represent a standard treatment approach for MTC.
- **Option D:** This option is incorrect because, although targeted therapy and chemotherapy may be considered in advanced or metastatic disease, they are not the primary treatment for MTC.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **calcitonin** and **CEA (carcinoembryonic antigen)** levels are useful tumor markers for monitoring disease recurrence and response to treatment in patients with medullary thyroid carcinoma. Elevated levels may indicate persistent or recurrent disease.

## **Correct Answer:** . Surgery